blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1253933

EP1253933 - USE OF NEUROTOXINS IN MEDICAMENTS FOR THYROID DISORDERS [Right-click to bookmark this link]
Former [2002/45]METHOD FOR TREATING THYROID DISORDERS
[2002/49]
StatusNo opposition filed within time limit
Status updated on  21.05.2004
Database last updated on 05.10.2024
Most recent event   Tooltip02.02.2007Lapse of the patent in a contracting state
New state(s): CY		published on 07.03.2007  [2007/10]
Applicant(s)For all designated states
ALLERGAN, INC.
2525 Dupont Drive
Irvine, CA 92612 / US
[N/P]
Former [2002/45]For all designated states
Allergan, Inc.
2525 Dupont Drive
Irvine, California 92612 / US
Inventor(s)01 / DONOVAN, Stephen
27252 Calle Anejo
Capistrano Beach, CA 92624 / US
 [2002/45]
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastrasse 30
81925 München / DE
[N/P]
Former [2002/45]HOFFMANN - EITLE
Patent- und Rechtsanwälte Arabellastrasse 4
81925 München / DE
Application number, filing date01910800.015.02.2001
[2002/45]
WO2001US04990
Priority number, dateUS2000050453815.02.2000         Original published format: US 504538
[2002/45]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO0160396
Date:23.08.2001
Language:EN
[2001/34]
Type: A2 Application without search report 
No.:EP1253933
Date:06.11.2002
Language:EN
The application published by WIPO in one of the EPO official languages on 23.08.2001 takes the place of the publication of the European patent application.
[2002/45]
Type: B1 Patent specification 
No.:EP1253933
Date:16.07.2003
Language:EN
[2003/29]
Search report(s)International search report - published on:EP14.03.2002
ClassificationIPC:A61K38/16, A61P5/14
[2002/45]
CPC:
A61K38/4893 (EP,US); A61P3/14 (EP); A61P5/14 (EP);
A61P5/16 (EP)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2002/45]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:VERWENDUNG VON NEUROTOXINEN IN MEDIKAMENTEN ZUR BEHANDLUNG VON THYROIDSTÖRUNGEN[2002/49]
English:USE OF NEUROTOXINS IN MEDICAMENTS FOR THYROID DISORDERS[2002/49]
French:UTILISATION DE NEUROTOXINES DANS DES MEDICAMENTS POUR LE TRAITEMENT DE TROUBLES THYROIDIENS[2002/49]
Former [2002/45]VERFAHREN ZUR BEHANDLUNG VON THYROIDSTÖRUNGEN
Former [2002/45]METHOD FOR TREATING THYROID DISORDERS
Former [2002/45]METHODE DE TRAITEMENT DE TROUBLES THYROIDIENS
Entry into regional phase13.08.2002National basic fee paid 
13.08.2002Designation fee(s) paid 
13.08.2002Examination fee paid 
Examination procedure07.09.2001Request for preliminary examination filed
International Preliminary Examining Authority: EP
13.08.2002Examination requested  [2002/45]
03.12.2002Communication of intention to grant the patent
20.03.2003Fee for grant paid
20.03.2003Fee for publishing/printing paid
Opposition(s)19.04.2004No opposition filed within time limit [2004/28]
Fees paidRenewal fee
25.02.2003Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT16.07.2003
BE16.07.2003
CH16.07.2003
CY16.07.2003
FI16.07.2003
LI16.07.2003
NL16.07.2003
TR16.07.2003
DK16.10.2003
GR16.10.2003
SE16.10.2003
PT16.12.2003
LU15.02.2004
IE16.02.2004
MC28.02.2004
[2007/10]
Former [2006/51]AT16.07.2003
BE16.07.2003
CH16.07.2003
FI16.07.2003
LI16.07.2003
NL16.07.2003
TR16.07.2003
DK16.10.2003
GR16.10.2003
SE16.10.2003
PT16.12.2003
LU15.02.2004
IE16.02.2004
MC28.02.2004
Former [2005/23]AT16.07.2003
BE16.07.2003
CH16.07.2003
FI16.07.2003
LI16.07.2003
NL16.07.2003
DK16.10.2003
GR16.10.2003
SE16.10.2003
PT16.12.2003
LU15.02.2004
IE16.02.2004
MC28.02.2004
Former [2005/19]AT16.07.2003
BE16.07.2003
CH16.07.2003
FI16.07.2003
LI16.07.2003
NL16.07.2003
DK16.10.2003
GR16.10.2003
SE16.10.2003
PT16.12.2003
IE16.02.2004
MC28.02.2004
Former [2005/02]AT16.07.2003
BE16.07.2003
CH16.07.2003
FI16.07.2003
LI16.07.2003
NL16.07.2003
DK16.10.2003
GR16.10.2003
SE16.10.2003
PT16.12.2003
MC28.02.2004
Former [2004/31]AT16.07.2003
BE16.07.2003
CH16.07.2003
FI16.07.2003
LI16.07.2003
NL16.07.2003
DK16.10.2003
GR16.10.2003
SE16.10.2003
PT16.12.2003
Former [2004/29]AT16.07.2003
BE16.07.2003
CH16.07.2003
FI16.07.2003
LI16.07.2003
NL16.07.2003
DK16.10.2003
GR16.10.2003
SE16.10.2003
Former [2004/28]AT16.07.2003
BE16.07.2003
CH16.07.2003
FI16.07.2003
LI16.07.2003
NL16.07.2003
GR16.10.2003
SE16.10.2003
Former [2004/22]AT16.07.2003
CH16.07.2003
FI16.07.2003
LI16.07.2003
NL16.07.2003
GR16.10.2003
SE16.10.2003
Former [2004/16]AT16.07.2003
FI16.07.2003
NL16.07.2003
GR16.10.2003
SE16.10.2003
Former [2004/14]AT16.07.2003
FI16.07.2003
NL16.07.2003
GR16.10.2003
Former [2004/12]FI16.07.2003
NL16.07.2003
Former [2004/10]NL16.07.2003
Cited inInternational search[A]WO9428922  (ALLERGAN INC [US]) [A] 1-20* the whole document *;
 [A]EP0770395  (ALLERGAN INC [US]) [A] 1-20 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.